Immunovia AB

Immunovia AB IMMNOV

Dividend Summary



There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status
Type
Per share
Declaration date
Ex-div date
Pay date

Enter the number of Immunovia AB shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for Immunovia AB
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Immunovia AB
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
There are no Immunovia AB dividends.
Year Amount Change
2006 0.0öre
2007 0.0öre
0%
2008 0.0öre
0%
2009 0.0öre
0%
2010 0.0öre
0%
2011 0.0öre
0%
2012 0.0öre
0%
2013 0.0öre
0%
2014 0.0öre
0%
2015 0.0öre
0%
2016 0.0öre
0%
2017 0.0öre
0%
2018 0.0öre
0%
2019 0.0öre
0%
2020 0.0öre
0%
2021 0.0öre
0%
2022 0.0öre
0%
2023 0.0öre
0%
2024 Sign Up Required

Immunovia AB Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 10 October 2023
52 Week Low
0.0% on 10 October 2023
Next Ex-Div-Date Countdown
Sign Up Required

About Immunovia AB

Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.

Sector
Pharmaceuticals & Biotechnology
Country
Sweden
Share Price
kr0.67 (yesterday's closing price)
Shares in Issue
181 million
Market Cap
kr121mn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
No articles found